Twist Bioscience (TWST) Change in Account Payables (2017 - 2026)

Twist Bioscience (TWST) has reported Change in Account Payables for 10 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Account Payables fell 4.85% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $4.3 million, a 9.33% decrease from a year earlier, with the FY2025 full-year figure at $9.3 million, up 179.05% from the prior year.
• Change in Account Payables was $3.0 million for Q2 2026 at Twist Bioscience, up from $69000.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $6.9 million in Q3 2022 and troughed at -$7.5 million in Q1 2023.
• A 5-year average of $388166.7 and a median of $390000.0 in 2025 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables soared 65740.0% in 2022 and slumped 889.83% in 2023, its largest moves.
• Over 5 years, Change in Account Payables stood at $3.3 million in 2022, then plunged by 228.12% to -$4.2 million in 2023, then soared by 235.81% to $5.7 million in 2024, then tumbled by 74.23% to $1.5 million in 2025, then jumped by 106.45% to $3.0 million in 2026.
• The last three Change in Account Payables figures came in at $3.0 million (Q2 2026), $69000.0 (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.